Results 301 to 310 of about 258,064 (337)

Proton Pump Inhibitors

2017
Guidelines generally recommend proton pump inhibitors (PPIs) over histamine type 2 receptor antagonists when acid suppression is advocated because of a longer duration of action, a superior ability in reducing acid secretion, and the absence of tachyphylaxis with repeated dosing.
Licia Pensabene, Geoffrey Davidson
openaire   +1 more source

Deprescribing Proton Pump Inhibitors

JAMA Internal Medicine, 2020
Jacob E, Kurlander, Juan J, Gonzalez, Sameer D, Saini   +2 more
openaire   +2 more sources

Proton pump inhibitors

British Dental Journal, 2010
openaire   +3 more sources

Proton pump inhibitors

Medical Journal of Australia, 1998
openaire   +2 more sources

Proton Pump Inhibitors

Clinical Gastroenterology and Hepatology, 2006
  +5 more sources

Combination therapy with clopidogrel and proton-pump inhibitors

Lancet, The, 2010
Neeraj B Bhala, Amitava Banerjee
exaly   +2 more sources

Proton pump

Science, 1998
openaire   +1 more source

Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials

Lancet, The, 2009
Michelle L O'donoghue, Eugene Braunwald, Elliott M Antman   +2 more
exaly  

Efficacy of chemotherapy and atezolizumab in patients with non-small-cell lung cancer receiving antibiotics and proton pump inhibitors: pooled post hoc analyses of the OAK and POPLAR trials

Annals of Oncology, 2020
Myriam Chalabi, Achim Rittmeyer, Matthew L Albert   +2 more
exaly  

Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trial

Lancet, The, 2007
Vivian Wing Yan Lee, Wai Keung Leung, Henry Lik Yuen Chan   +2 more
exaly